Cellect Biotechnology

$0.5265
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.009 (-1.68%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell APOP and other stocks, options, ETFs, and crypto commission-free!

About APOP

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. Read More The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. Cellect Biotechnology was founded by Kasbian Nuriel Chirich, Shai Yarkoni and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.

Employees
28
Headquarters
Kfar Saba, Jerusalem
Founded
1986
Market Cap
3.00M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.33M
High Today
$0.55
Low Today
$0.51
Open Price
$0.5419
Volume
54.74K
52 Week High
$6.01
52 Week Low
$0.4025

Collections

APOP News

BenzingaAug 13

Cellect Biotechnology Reports Second Quarter 2019 Financial and Operating Results

229

APOP Earnings

-$0.19
-$0.17
-$0.15
-$0.13
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual

More APOP News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.